papaverine has been researched along with prednisolone in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chłoń-Rzepa, G; Dąbrowska, M; Jankowska, A; Komsta, Ł; Pawłowski, M; Ślusarczyk, M; Starek, M; Zagórska, A | 1 |
| Eandi, M; Molinengo, L | 1 |
| Hidaka, T | 1 |
| Burgaud, JL; Del Soldato, P; Oudart, N; Tallet, D | 1 |
| MAURO, R; MIRACCO, A | 1 |
| RITTER, U | 1 |
| Haslam, JL; Sotthivirat, S; Stella, VJ | 1 |
1 review(s) available for papaverine and prednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for papaverine and prednisolone
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Estimation of the lipophilicity of purine-2,6-dione-based TRPA1 antagonists and PDE4/7 inhibitors with analgesic activity.
Topics: Analgesics; Benzeneacetamides; Cyclic Nucleotide Phosphodiesterases, Type 7; Hydrophobic and Hydrophilic Interactions; Molecular Structure; Phenylbutyrates; Phosphodiesterase 4 Inhibitors; Principal Component Analysis; Quantitative Structure-Activity Relationship; TRPA1 Cation Channel; Xanthines | 2021 |
[Action of drugs on phagocytosis. II. Evaluation of several substances].
Topics: Aminopyrine; Anti-Inflammatory Agents; Atropine; Histamine; Lactobacillus; Leukocytes; Papaverine; Phagocytosis; Prednisolone; Quinolines; Sodium Salicylate | 1970 |
[Effects of various therapeutic agents on hemorrhagic diathesis and blood clotting factors in aged patients with cerebrovascular disorders].
Topics: Adrenochrome; Aged; Blood Coagulation; Blood Coagulation Tests; Cerebrovascular Disorders; Female; Hemorrhagic Disorders; Humans; Hydrochlorothiazide; Hydroquinones; Lipids; Male; Middle Aged; Nicotinic Acids; Papaverine; Prednisolone; Reserpine; Streptodornase and Streptokinase; Sulfonic Acids; Vitamins | 1972 |
NO-steroids: potent anti-inflammatory drugs with bronchodilating activity in vitro.
Topics: Animals; Anti-Inflammatory Agents; Bronchi; Bronchoconstrictor Agents; Bronchodilator Agents; Dexamethasone; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guinea Pigs; Inflammation; Methacholine Chloride; Models, Chemical; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Culture Techniques; Papaverine; Perfusion; Phosphodiesterase Inhibitors; Prednisolone; Steroids; Trachea; Vasodilator Agents | 2002 |
[ON A NEW DIAGNOSTIC AND THERAPEUTIC TECHNIC OF COLON DISORDERS].
Topics: Chloramphenicol; Colitis; Colitis, Ulcerative; Colonic Diseases; Enema; Equipment and Supplies; Humans; Khellin; Papaverine; Prednisolone; Radiography; Sigmoidoscopy; Solutions; Sulfaguanidine; Sulfathiazoles; Thrombin | 1964 |
[DIAGNOSIS AND TREATMENT OF PANCREATITIS].
Topics: Amylases; Anti-Bacterial Agents; Antibiotics, Antitubercular; Atropine; Chyle; Clinical Enzyme Tests; Dermatologic Agents; Diagnosis; Humans; Hypertension; Norepinephrine; Pancreatitis; Papaverine; Prednisolone; Prednisone; Strophanthins | 1963 |
Evaluation of various properties of alternative salt forms of sulfobutylether-beta-cyclodextrin, (SBE)7M-beta-CD.
Topics: beta-Cyclodextrins; Calcium; Delayed-Action Preparations; Diffusion; Drug Delivery Systems; Ethylenediamines; Osmolar Concentration; Papaverine; Potassium; Prazosin; Prednisolone; Sodium; Solubility; Testosterone; Viscosity | 2007 |